Interleukin-22: immunobiology and pathology
- PMID: 25706098
- PMCID: PMC4407497
- DOI: 10.1146/annurev-immunol-032414-112123
Interleukin-22: immunobiology and pathology
Abstract
Interleukin-22 (IL-22) is a recently described IL-10 family cytokine that is produced by T helper (Th) 17 cells, γδ T cells, NKT cells, and newly described innate lymphoid cells (ILCs). Knowledge of IL-22 biology has evolved rapidly since its discovery in 2000, and a role for IL-22 has been identified in numerous tissues, including the intestines, lung, liver, kidney, thymus, pancreas, and skin. IL-22 primarily targets nonhematopoietic epithelial and stromal cells, where it can promote proliferation and play a role in tissue regeneration. In addition, IL-22 regulates host defense at barrier surfaces. However, IL-22 has also been linked to several conditions involving inflammatory tissue pathology. In this review, we assess the current understanding of this cytokine, including its physiologic and pathologic effects on epithelial cell function.
Keywords: epithelial cells; interleukin-22; tissue regeneration.
Figures
Similar articles
-
MicroRNAs: New regulators of IL-22.Cell Immunol. 2016 Jun-Jul;304-305:1-8. doi: 10.1016/j.cellimm.2016.05.003. Epub 2016 May 17. Cell Immunol. 2016. PMID: 27221197 Review.
-
Distribution of Interleukin-22-secreting Immune Cells in Conjunctival Associated Lymphoid Tissue.Korean J Ophthalmol. 2018 Apr;32(2):147-153. doi: 10.3341/kjo.2017.0068. Epub 2018 Mar 19. Korean J Ophthalmol. 2018. PMID: 29560621 Free PMC article.
-
A comprehensive review of IL-26 to pave a new way for a profound understanding of the pathobiology of cancer, inflammatory diseases and infections.Immunology. 2022 Jan;165(1):44-60. doi: 10.1111/imm.13424. Epub 2021 Nov 8. Immunology. 2022. PMID: 34716913 Review.
-
Functional biology of the IL-22-IL-22R pathway in regulating immunity and inflammation at barrier surfaces.Adv Immunol. 2010;107:1-29. doi: 10.1016/B978-0-12-381300-8.00001-0. Adv Immunol. 2010. PMID: 21034969 Review.
-
IL-22, not simply a Th17 cytokine.Immunol Rev. 2013 Mar;252(1):116-32. doi: 10.1111/imr.12027. Immunol Rev. 2013. PMID: 23405899 Review.
Cited by
-
Non-canonical IL-22 receptor signaling remodels the mucosal barrier during fungal immunosurveillance.bioRxiv [Preprint]. 2024 Sep 13:2024.09.08.611873. doi: 10.1101/2024.09.08.611873. bioRxiv. 2024. PMID: 39314368 Free PMC article. Preprint.
-
Subpopulation dynamics of T and B lymphocytes in Sjögren's syndrome: implications for disease activity and treatment.Front Immunol. 2024 Sep 3;15:1468469. doi: 10.3389/fimmu.2024.1468469. eCollection 2024. Front Immunol. 2024. PMID: 39290700 Free PMC article. Review.
-
IL-22: A key inflammatory mediator as a biomarker and potential therapeutic target for lung cancer.Heliyon. 2024 Aug 10;10(17):e35901. doi: 10.1016/j.heliyon.2024.e35901. eCollection 2024 Sep 15. Heliyon. 2024. PMID: 39263114 Free PMC article. Review.
-
Assessment of immune responses to a Comirnaty® booster following CoronaVac® vaccination in healthcare workers.Mem Inst Oswaldo Cruz. 2024 Sep 9;119:e230239. doi: 10.1590/0074-02760230239. eCollection 2024. Mem Inst Oswaldo Cruz. 2024. PMID: 39258622 Free PMC article.
-
The role of IL-22 in cancer.Med Oncol. 2024 Sep 5;41(10):240. doi: 10.1007/s12032-024-02481-8. Med Oncol. 2024. PMID: 39231878 Review.
References
-
- Dumoutier L, Van Roost E, Ameye G, Michaux L, Renauld JC. IL-TIF/IL-22: genomic organization and mapping of the human and mouse genes. Genes Immun. 2000;1:488–494. - PubMed
-
- Xie MH. Interleukin (IL)-22, a novel human cytokine that signals through the interferon receptor-related proteins CRF2–4 and IL-22R. J. Biol. Chem. 2000;275:31335–31339. - PubMed
-
- Nagem RA. Crystal structure of recombinant human interleukin-22. Structure. 2002;10:1051–1062. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- R01 AI101406/AI/NIAID NIH HHS/United States
- HHSN272200900059C/AI/NIAID NIH HHS/United States
- R01 HL069929/HL/NHLBI NIH HHS/United States
- P01-CA023766/CA/NCI NIH HHS/United States
- P30 CA072720/CA/NCI NIH HHS/United States
- P01 CA023766/CA/NCI NIH HHS/United States
- K99 CA176376/CA/NCI NIH HHS/United States
- R01 AI080455/AI/NIAID NIH HHS/United States
- K99-CA176376/CA/NCI NIH HHS/United States
- P30 CA008748/CA/NCI NIH HHS/United States
- R01-AI100288/AI/NIAID NIH HHS/United States
- R01-HL069929/HL/NHLBI NIH HHS/United States
- R01 AI100288/AI/NIAID NIH HHS/United States
- K08 HL115355/HL/NHLBI NIH HHS/United States
- K08-HL115355/HL/NHLBI NIH HHS/United States
- R01-AI101406/AI/NIAID NIH HHS/United States
- R01-AI080455/AI/NIAID NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources